A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction.
Gut
Tian, Sun S; Simon, Iris I; Moreno, Victor V; Roepman, Paul P; Tabernero, Josep J; Snel, Mireille M; van't Veer, Laura L; Salazar, Ramon R; Bernards, Rene R; Capella, Gabriel G